Today RNS......7 Aug 2019 08:57
"The Company intends to issue a total of 36,047,502 new ordinary shares of 25 pence each ("New Ordinary Shares") at a price of 40 pence per share (the "Issue Price"), totalling approximately £14.4 million (the "Issue of Equity"). In addition, the Company has entered into a loan facility agreement with Nerano Pharma Limited* for £4.0 million (the "Loan"), further details of which are set out below."
Not too bad considering the placing price is above the current.....so hopefully the next news is tech. update,and those takers of the placing shares surely confident enough about positive outcome .